A Legacy of healthy Living
Ways to enhance your life and health
Legacy Distribution Group is one of the county’s first CBD-focused Direct Store Delivery (DSD) distributors. CBD Global Sciences’ Legacy Distribution Group is excited to announce the addition of Gorilla Hemp to its family of brands. Legacy will be carrying the Gorilla Hemp line and expects it to be a very successful product in their portfolio.
Brad Wyatt, CEO of CBD Global Sciences shared “I am excited to see the interest from multiple large and successful CBD infused brands like Gorilla Hemp. Gorilla Hemp is trailblazing the energy drink space that combines ingredients that boost physical stamina and mental clarity with the wellness effects of 20MG of CBD. They are proving to be an innovator in the space with health and performance at mind for its consumers. We look forward to adding to their total points of distribution with Legacy Distribution”.
ABOUT GORILLA HEMP
Elegance Brands recently entered the U.S. market via their first exclusive distribution deal with KC distributing in Texas for Gorilla Hemp, a nonalcoholic, CBD-based energy drink. According to the company, this energy drink “combines ingredients that boost physical stamina and mental clarity with the wellness effects of 20mg Hemp CBD, delivering a balanced experience that optimizes performance throughout the day.” Gorilla Hemp is a carbonated beverage that contains a unique combination of functional ingredients, including 20mg Hemp CBD isolate, 160mg green coffee caffeine, and natural plant extracts. Their proprietary formulation was designed to optimize both mental and physical performance, while providing balance and other wellness benefits associated with CBD. Harnessing the best ingredients nature has to offer, Gorilla Hemp provides maximum energy alongside mental clarity. Guarana, green coffee caffeine, and B vitamins provide a stimulating effect, while ginseng and gingko biloba improve brain function with their antioxidant properties. The addition of high-quality hemp CBD isolate gives balance to the blend, and helps speed recovery times with its anti-inflammatory qualities.
CBD Global Sciences, Inc. is pleased to announce that it will present at the LD Micro 14th Annual Main Event.
CBD Global President and CEO, Brad Wyatt, is scheduled to present at the event that will be hosted both live and virtual presentations to Analysts and Institutional Investors. His presentation was recorded prior to the Company’s announcement of its pending acquisition of the cGMP manufacturing company, Resinosa, and will go into greater depth about the Company operations into 2022.
Event: 14th Annual LD Micro Main Event Presentation
Date: Tuesday, October 12th
Presentation Time: 9:00 am – 9:25 am EDT
Register to watch the virtual Presentation here or go to https://me21.mysequire.com.
Brad Wyatt, CEO of CBD Global Sciences shared “This is an exciting opportunity for CBD Global to share with the investors and industry analysts about our company and all the positive news around our exciting business plan. This will be our second appearance at this event while Sequire continues to expand its reach and investor base, very impressive! What a great way to get the word out to the investor community”.
ABOUT CBD GLOBAL SCIENCES INC.
CBD Global Sciences, Inc., is a hemp-based CBD producer and branding investment vehicle which currently owns two brands, branded under the name Aethics™ (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals,
Hydration products and Confectionary products. CBD Global Sciences hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.
CBD Global Sciences, through its wholly owned subsidiaries, Global Sciences Holdings, Resinosa LLC (www.resinosa.com) and Legacy Distribution Group, (www.legacydistributiongroup.com ), is delivering quality CBD products both in a retail and e-commerce formats nationwide. The DSD provides distribution services for multiple vendors of CBD infused products and non-CBD products throughout the Colorado and Wyoming territories (direct store delivery) currently servicing over 400 C-store and large box retailers with expansion plans to exceed 5,000 stores in the next 12-24 months. With the soon to be added manufacturing division, Resinosa LLC, it will have the capabilities to provide cGMP manufacturing to the CBD industry with both private label and white label CBD and non-CBD product lines.
CBD Global Sciences, Inc. is pleased to announce that it has executed a definitive agreement for the acquisition of 100% of Resinosa LLC, a CBD company located in Silver Cliff Colorado.
Resinosa has been in business in the CBD industry for over 6 years and is a vertically integrated company with expertise in hemp genetics, cloning, farming, harvesting, processing and manufacturing of finished products. Resinosa owns a commercial clean-room facility that is registered with the Food and Drug Administration, is certified under stringent current Good Manufacturing Practices (cGMP) standards and has been outfitted specifically for processing hemp and manufacturing health and wellness products such as food, dietary supplements and topical products. Resinosa is licensed as a Manufactured Food Facility with the Colorado Department of Health and the Environment and the City of Denver, Colorado for shelf stability of their products. Located in a low cost of living area, Silver Cliff presents a cost advantage when it comes to processing and manufacturing products.
With its current assets, Resinosa can conduct extraction and processing operations on hemp biomass to produce 1,320 kilos of full spectrum CBD oil per month. That amount of full spectrum oil can be formulated into an estimated retail value of $46,200,000.00* of finished products per month. Resinosa’s primary business is supplying companies with branded CBD finished products, referred to as private label or white label. Their clients include companies specializing in medical grade products, pet and veterinary products, CBD cosmetic products, farmers with their own brands and companies who add CBD products to their existing businesses such as spas and biofeedback centers.
*Based on a 22-day work month, one eight-hour shift per day with current staff and equipment. Assumes finished product sold with an average MSRP of $70 at two grams of CBD per unit sold. This is strictly an example of current production ability.
Resinosa’s CEO and founder Jeff Hays, holds a Master of Business Administration from the University of Southern California and a B.S. in Civil Engineering from the University of Arizona. The company’s Vice President of Quality Control and General Counsel, Kathy Hays, is an attorney licensed in three states and holds a Juris Doctor degree from Loyola Law School, an M.S. in Systems Management from the University of Southern California, and a B.S in Aerospace Engineering. Both Mr. and Mrs. Hays served in the U.S. Air Force – Jeff as a pilot and engineer and Kathy as a space launch expert.
Resinosa’s Director of Operations, Jared Baker, holds a degree in Fire Safety from Oklahoma State University. The company’s chemist, Rebecca Collins, holds a B.S. in chemistry from the University of Texas and has experience in the pharmaceutical industry. Their chef, Shane Dean, was professionally trained at Le Cordon Bleu in Scottsdale, AZ. Resinosa’s Compliance Manager, Jimmie Faye Mowery, was trained in the pharmaceuticals industry and ran her own CBD products brand.
Brad Wyatt, CEO of CBD Global Sciences shared “Throughout my many years in corporate and private company management I found it critical to surround myself with extremely smart and talented people. I’ve been able to get to know and respect the team that Resinosa brings to the table and am ecstatic to see them join the CBD Global family. This acquisition is strategic in nature and will dovetail nicely into the supply chain with Legacy Distribution Group. Giving CBD Global the ability to formulate and manufacturer both CBD and non-CBD products while having the ability to place new products directly into the market with points of distribution created by Legacy Distribution Group will prove advantageous to the Company and its shareholders. I am confident that the addition to our Company will prove wildly successful and I know they will hit the ground running! ”
CBD Global Sciences, Inc. (OTC: CBDNF) (CSE: CBDN) (Frankfurt:GS3), “CBD Global” or the “Company”), is pleased to share that a recent study has revealed that CBD may be key to stopping triggers for Alzheimer’s disease, according to researchers from the Medical College of Georgia in Augusta University.
Cannabidiol, or CBD, continues to gain support as a remedy for everything from stress to bacterial infections. A new study reveals marijuana’s non-psychoactive ingredient may also be the key to stopping the triggers for Alzheimer’s disease. Researchers from the Medical College of Georgia at Augusta University say high doses of CBD restores the function of key proteins that clean up beta-amyloid plaque buildups in the brain. These clumps are one of the major causes of Alzheimer’s disease, the most common form of dementia.
Their study finds a two-week treatment course in mice boosted the proteins TREM2and IL-33, both of which contribute to the brain’s immune cells being able to clean out dead cells and other debris in the body. When plaques pile up in the brain, they start interfering with the communication between neurons and lead to brain cell death. Levels of both proteins decrease in patients with Alzheimer’s. For the first time, investigators report that CBD treatments normalized the levels of these proteins. CBD also helped to improve cognitive function in mice with a form of early onset familial Alzheimer’s disease. Dr. Babak Baban, an immunologist and associate dean for research in the Dental College of Georgia, says CBD helped to reduce levels of IL-6. Researchers believe this particular immune protein has a link to high levels of inflammation in Alzheimer’s patients. (Source: Study Finds )
Brad Wyatt, CEO of CBD Global Sciences shared “I always knew that science would be an integral for the approval and deployment of CBD and other cannabinoids for global use as a treatment for a multitude of ailments. We are seeing this happen on many different fronts, further proving the need for the all-natural remedy for the human body. I truly believe that we will discover through research and clinical trials that the basic compounds found in the cannabis plant will continue to fill a plethora of deficiencies that the human body needs.”
Legacy is excited and motivated to build upon Mad Tasty’s significant sales success and help them to fully capture the Colorado market.
Brad Wyatt, CEO of CBD Global, shared, “Another addition to the Legacy Distribution family of quality CBD infused beverages. MAD TASTY has proven to be an innovator in the space and has partnered with incredible collaborators to bring its beverage to market. We look forward to working with the team at Mad Tasty.”
ABOUT MAD TASTY
MAD TASTY is a sparkling water with zero sugar or sweeteners and 20 mg of hemp extract founded by musician and songwriter Ryan Tedder, lead singer of OneRepublic. Clean, all-natural, and hydrating, MAD TASTY is a low-calorie functional beverage that expands bandwidth for a refreshing experience that keeps energy up all day. Collaborators with Ryan in the creation and marketing of Mad Tasty include First Bev, a private equity fund focused 100% on the beverage industry, Interscope, one of the world’s premier record labels and Sorse Technology ™ which is a technology company that houses the MAD scientist who created the formulation for the beverage. For every 12 oz can sold, MAD TASTY donates 12 oz of clean water through DROP4DROP, which gives clean drinking water to people and places in need. Available in two fresh flavors, Grapefruit and Watermelon Kiwi, non-GMO, vegan and gluten-free, MAD TASTY is available in Southern California, Texas, Colorado and other hemp friendly states, as well as online at www.MADTASTY.com .
Legacy will be carrying the full line of Marley CBD beverage products and is excited to add the already outstanding success of the brand to its lineup of CBD infused brands. Brad Wyatt, CEO of CBD Global, shared, “The team at Legacy Distribution has done a phenomenal job in the startup and rapid growth of the distribution channel, not only with adding quality CBD vendors such as Marely but in the growth of points of distribution. We are adding new trucks and drivers to support the new routes weekly, all very exciting! We look forward to adding to their total points of distribution with Legacy Distribution.”
About Docklight Brands, Inc.
Docklight Brands is a pioneering consumer brand company crafting the futures of the rapidly-emerging, legal cannabis and cannabinoid industries. Docklight’s focus is on building lasting cannabis and hemp-derived brands that consumers crave. Docklight uses their deep understanding of consumer needs states and category trends, to create brands that resonate with consumers and are among the bestselling cannabis and hemp-derived brands on the market ( www.docklightbrands.com ).
Until now, CBD brands have had to rely heavily on distributors that may be as new to CBD as the customers they service. While many of these distributors have a long track record of success, their lack of CBD expertise and broader, mostly traditional brand portfolios routinely result in the underperformance of the CBD brands they represent. This is the problem Legacy aims to solve. By providing best-in-class service and unmatched CBD expertise, Legacy’s curated approach is designed specifically to help maximize the growth and market penetration of new and existing CBD brands. Currently, Legacy has begun vetting a new round of CBD brands to be included in their growing portfolio.
CBD Global has enlisted a team of highly skilled distribution and sales managers that have honed their expertise in large scale DSD over the past several decades. The assembly of this team is a collaborative effort with people and companies that have successfully managed and navigated the creation and growth of distribution channel services and we are pleased to launch this project. The team at Legacy Distribution collectively has nearly three decades of experience in DSD operations and nearly a decade long track record of sales success in the CBD space. This unique combination results in an unparalleled ability to successfully open and effectively service new accounts on behalf of the brands in their portfolio. Legacy Distribution has acquired distribution and sales routes that consists of approximately 1,000 points of distribution in the Colorado and surrounding region. These routes were established with CBD infused product early 2019 and continue to grow with seven major brands being represented.
Brad Wyatt, CEO of CBD Global Sciences shared “direct store delivery is a big piece of my corporate background, running large scale distribution facilities for companies like Target Corporation, Sears Roebuck and Federal Mogul. I’ve found that to be successful in this space leadership needs to surround themselves with solid operators that possess incredible relationships. In the coming months we will be able to share more information about the team, the growing list of distribution agreements with multiple large-scale brands and the likes. We are extremely excited to bring this to the CBD industry with the intent to provide a quicker, more efficient and more affordable path to sales for the CBD Brands that are trying to get their products on the shelf”.